老年冠心病患走者心脏康复治疗的基本概念.pptVIP

HM734 Exercise Testing and Prescription: Cardiorespiratory * Actuarial cumulative hazard plot for survival time based on depression status upon completion of cardiac rehabilitation Depressed Non-depressed 0 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0 1 2 3 4 5 Time (Years) Depression is Associated with Decreased Survival Milani RV, Am J Med 2007 HM734 Exercise Testing and Prescription: Cardiorespiratory * Prevalence of Depression Before and After Cardiac Rehab 23% 19% 30 20 0 Young Elderly 10 6% 4% Before After Lavie CF, Arch Int Med, 2006 Psychological Distress is Common HM734 Exercise Testing and Prescription: Cardiorespiratory * 34 HM734 Exercise Testing and Prescription: Cardiorespiratory * * * * * So these are the people that we envisage should be involved with secondary prevenion according to the NSF for CHD. * RFA list Family * Cumulative Kaplan-Meier estimates of the rates of key study end points during the follow-up period among 3241 patients with recent myocardial infarction (MI). A, Data for the primary composite end point (cardiovascular mortality, nonfatal MI, nonfatal stroke, and hospitalization for angina pectoris, heart failure, or urgent revascularization procedure). The hazard ratio (HR) for the intensive intervention, compared with usual care, for the primary efficacy end point at the study end was 0.88 (95% confidence interval [CI], 0.74-1.04; P?=?.12). B, Data for the secondary efficacy end point (death from cardiovascular causes, nonfatal MI, or nonfatal stroke). The HR for the intensive intervention, compared with usual care, for the primary efficacy end point at the study end was 0.67 (95% CI, 0.47-0.95; P?=?.02). C, Data for the secondary efficacy end point (cardiac death plus nonfatal MI). The HR for the intensive intervention, compared with usual care, for the primary efficacy end point at the study end was 0.64 (95% CI, 0.43-0.94; P?=?.02). D, Data for the secondary efficacy end point (fatal plus nonfatal stroke). The HR for the intensive in